NEW ORLEANS – The landscape of reconstructive medicine is poised for a significant shift in strategic direction following the appointment of Babak J. Mehrara, MD, as the new president of The Plastic Surgery Foundation (The PSF). The announcement, which took place during Plastic Surgery The Meeting—the American Society of Plastic Surgeons’ (ASPS) premier annual scientific conference—marks the beginning of a one-year tenure characterized by a heightened focus on high-impact research, lymphatic innovation, and the mentorship of the next generation of surgical scientists.
Dr. Mehrara, a preeminent figure in oncologic reconstruction, officially assumed the presidency on October 12, 2025. He is slated to lead the organization until October 18, 2026, a period that many in the medical community believe will be pivotal for the integration of clinical research and patient-centric surgical solutions.
The Core Mandate: Leadership and Vision
As the philanthropic and research arm of the American Society of Plastic Surgeons, The PSF serves as the engine room for the specialty’s academic and humanitarian efforts. The Foundation’s mission centers on fostering research, driving education, and expanding access to surgical care.
"It’s an honor to lead The PSF, and I look forward to building on its legacy of excellence in plastic surgery research and innovation," Dr. Mehrara stated during his inaugural address at the New Orleans conference. "I am deeply committed to the advancement of scientific discovery and supporting the work of residents, early-career researchers, and emerging innovators. Throughout my presidency, I will champion new ways to strengthen and expand the Foundation’s mission of research and education."
Dr. Mehrara’s vision is not merely administrative; it is deeply rooted in his personal experience as a surgeon-scientist who has navigated the challenges of translating laboratory findings into bedside care. His primary objective is to bridge the gap between academic discovery and clinical implementation, ensuring that the findings funded by The PSF translate into tangible, improved patient outcomes.
Chronology: A Trajectory of Excellence
To understand the significance of Dr. Mehrara’s appointment, one must look at the path that led him to the helm of The PSF. His career is defined by a consistent pursuit of knowledge at the intersection of surgery and oncology.
- Academic Foundations: Dr. Mehrara’s career began with rigorous training that established his reputation as a clinician-researcher. His expertise has been honed through years of surgical practice and academic inquiry.
- The MSK Tenure: Currently serving as the Chief of the Plastic and Reconstructive Surgery Service at Memorial Sloan Kettering Cancer Center (MSK), Dr. Mehrara has transformed the service into a global leader in oncologic reconstruction. His role as the Peter G. Cordeiro Endowed Chair in the Department of Surgery serves as a testament to his influence within the institution.
- Lymphatic Research: For over a decade, Dr. Mehrara has been a driving force in the study of lymphedema. Under his direction, the National Institutes of Health (NIH)-funded Lymphatic Biology Laboratory at MSK has become a world-renowned facility.
- October 12, 2025: Dr. Mehrara is officially inaugurated as President of The Plastic Surgery Foundation at Plastic Surgery The Meeting in New Orleans.
- The Year Ahead (2025–2026): His term, which concludes in October 2026, will focus on scaling the foundation’s research infrastructure and fostering collaborative partnerships.
Supporting Data: The Impact of a Scholar-Surgeon
Dr. Mehrara’s appointment is backed by a body of work that is as prolific as it is impactful. A leader in the surgical and nonsurgical treatment of cancer-related lymphedema, he has authored more than 400 peer-reviewed publications. This volume of work is significant in the medical field, as it reflects a career dedicated to rigorous evidence-based practice.
The Lymphatic Biology Lab
The NIH-funded laboratory under his direction serves as a blueprint for the kind of "high-impact research" he intends to promote during his presidency. His work on lymphatic diseases has provided critical insights into the pathology of secondary lymphedema in breast cancer survivors, a condition that historically had few effective treatments. By focusing on molecular pathways and regenerative medicine, Dr. Mehrara’s team has helped pioneer surgical interventions that improve the quality of life for cancer survivors.
Academic Stewardship
Beyond his research, Dr. Mehrara’s role as a Professor of Surgery at Weill Cornell Medical College ensures that the next generation of plastic surgeons is being trained by a leader who values both clinical skill and scientific inquiry. His joint appointment reflects his belief that the future of plastic surgery is inextricably linked to academic medicine.
Implications for the Future of Plastic Surgery
The presidency of Dr. Mehrara comes at a time when the specialty of plastic surgery is evolving rapidly. The implications of his tenure extend across several key areas:
1. Advancing Oncologic Reconstruction
Under his leadership, The PSF is expected to increase its focus on reconstructive challenges post-cancer. As cancer survival rates improve, the demand for high-quality, functional, and aesthetic reconstruction has grown. Dr. Mehrara’s expertise ensures that these issues will remain at the forefront of the foundation’s grant-making priorities.
2. Mentorship and the Next Generation
Dr. Mehrara has explicitly stated his commitment to "supporting the work of residents, early-career researchers, and emerging innovators." This implies a potential increase in funding for junior investigator grants and the development of mentorship networks designed to guide young surgeons through the often-arduous process of securing research funding and publishing high-impact studies.
3. Global Reach and Collaborative Partnerships
The PSF is known for its international activities, and Dr. Mehrara intends to expand this reach. By building partnerships with global health organizations, he aims to improve access to "safe, effective, and affordable plastic surgery care." This aligns with a growing global trend toward closing the gap in surgical care, particularly in low- and middle-income countries where access to reconstructive surgery is often limited.
Official Responses and Industry Sentiment
The selection of Dr. Mehrara has been met with broad approval from the medical establishment. Peers note that his dual capacity as a surgeon at a premier cancer center and a principal investigator at an NIH-funded lab makes him uniquely qualified to lead a foundation that balances research and clinical application.
"Dr. Mehrara is a rare talent who understands the language of the laboratory and the realities of the operating room," noted a representative from the American Society of Plastic Surgeons. "His appointment signals that The PSF is moving toward a future where research is not just an academic exercise, but a clinical imperative."
Colleagues at Memorial Sloan Kettering Cancer Center have echoed this sentiment, emphasizing that his leadership style—which prioritizes collaborative inquiry and rigorous scientific standards—will likely revitalize the foundation’s grant programs.
Conclusion: A New Era for The PSF
As Dr. Mehrara steps into this role, the medical community looks forward to seeing how his research-heavy background will reshape the Foundation’s strategic goals. The next twelve months are expected to see a greater emphasis on the infrastructure of innovation—specifically, how the Foundation can better facilitate multi-institutional studies and bridge the "valley of death" between bench-side research and clinical practice.
With a firm grasp on the challenges facing modern plastic surgery, from the complexities of lymphatic reconstruction to the necessity of training the next generation of surgical scientists, Dr. Mehrara is well-positioned to steer The Plastic Surgery Foundation toward a period of renewed academic vigor. His term will be defined not just by what is accomplished in the boardroom, but by how successfully the foundation can cultivate the ideas that will eventually change the standard of care for patients worldwide.
As the industry watches his progress, one thing is clear: the integration of clinical excellence and scientific rigor, championed by Dr. Mehrara, will serve as the guiding philosophy for The PSF throughout his term. The legacy of the foundation is in capable hands, and the potential for advancements in plastic and reconstructive surgery has never been higher.
About the Author
